Orange, CANCT06511037Now EnrollingIRB Ready

Gastrointestinal Cancer Clinical Trial in Orange, CA

Access cutting-edge gastrointestinal cancer treatment through this early phase 1 clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.

Sponsored by University of California, Irvine

Quick Self-Assessment

See if you qualify for this Orange location

Preparing your pre-screening questions…

Expert Care in Orange

Access gastrointestinal cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related gastrointestinal cancer treatment provided free

Apply for This Orange Location

Check if you qualify for this gastrointestinal cancer clinical trial in Orange, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Orange

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Orange site if eligible
  4. 4Begin participation

About This Gastrointestinal Cancer Study in Orange

This is a pilot, single-arm, open label study to evaluate the ability of CYTALUX™ (pafolacianine) to help identify cancerous lesions in subjects with gastrointestinal cancers and peritoneal carcinomatosis during cytoreductive surgery.

Sponsor: University of California, Irvine

Who Can Participate

Inclusion Criteria

Adult patients 18 years of age and older
Have a primary diagnosis of primary gastrointestinal cancer (of adenocarcinoma), planned for cytoreductive surgery
Female patients must have a negative serum pregnancy test at screening, followed by a negative urine pregnancy test on the day of scheduled study drug infusion, or day of surgery
Female patients of childbearing potential, or less than two (2) years postmenopausal, agree to use an acceptable form of contraception from time of signing informed consent until 30 days after study completion
Ability to understand the requirements of the study, provide written informed consent for participation in the study and authorization of use and disclosure of protected health information, and agree to abide by study restrictions

Exclusion Criteria

Previous exposure to CYTALUX™ (PAFOLACIANINE)
Patients with known gastrointestinal cancer with carcinomatosis determined pre-operatively to be inoperable
Any medical condition that in the opinion of the investigators could potential jeopardize the safety of the patient
History of anaphylactic reaction
History of allergy to any components of CYTALUX™ (PAFOLACIANINE), including folic acid
Pregnancy, or positive pregnancy test
Clinically significant abnormalities on ECG
Impaired renal function defined as eGFR \<50 mL/min/1.73m2
Impaired liver function defined as values \>3x the upper limit of normal (ULN) for alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), or total bilirubin
Received an investigational agent in another trial within 30 days prior to surgery
Known sensitivity to fluorescent light

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Orange?

Yes, this clinical trial (NCT06511037) has an active research site in Orange, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Gastrointestinal Cancer Treatment Options in Orange, CA

If you're searching for gastrointestinal cancer treatment options in Orange, CA, this clinical trial (NCT06511037) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Orange research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced gastrointestinal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all gastrointestinal cancer clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Orange, CA

See all ankylosing spondylitis clinical trials recruiting in Orange — not just this study.

Browse Ankylosing Spondylitis Trials in Orange →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsGeographic Atrophy TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Orange?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Orange, CA